• HOME (current)
  • MEETINGS ARCHIVE
    2019 RANZCO 2018 RANZCO 2017 RANZCO 2016 RANZCO 2015 RANZCO 2014 RANZCO 2013 RANZCO 2012 RANZCO
  • ADVANCED SEARCH
  • 2016 RANZCO HANDBOOK
Home > 2019 RANZCO

2019 RANZCO , 51st Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists

08 November – 12 November 2019 in Sydney, Australia


View By Number View By Title View Sessions
ABSTRACT NUMBER : A1
Vascularised congenital cataract removal
ABSTRACT NUMBER : A10
Phacoemulsification training for small manual incision cataract surgery experienced Nepalese surgeons: A joint project of Queensland ophthalmologists and Lumbini Eye Institute
ABSTRACT NUMBER : A100
Outcomes of uveitic glaucoma treatment
ABSTRACT NUMBER : A101
Trend analysis of common glaucoma procedures over the last decade
ABSTRACT NUMBER : A102
A review of the efficacy of first generation iStent in patients with glaucoma at Auckland City Hospital
ABSTRACT NUMBER : A103
OCT Angiography in Optic Disc Haemorrhage (ODH): Intra‐individual case‐control comparison of glaucoma patients
ABSTRACT NUMBER : A104
In vivo trabecular meshwork morphology in congenital glaucoma, juvenile and adult onset open angle glaucoma: a comparative study
ABSTRACT NUMBER : A105
Optimizing yoga postures for lifestyle management in glaucoma
ABSTRACT NUMBER : A106
Pronase E improves gene transduction of retinal ganglion cells
ABSTRACT NUMBER : A107
Comparison of RNFL and GCLIPL thicknesses and progression characteristics using two OCT systems: The PROGRESSA Study
  • 1
  • 2
  • 3
  • …
  • 38
  • Next »
Advanced Search

MOST VIEWED ABSTRACTS


  • This Week
  • This Month
  • All Time

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Retinal Vascular Changes in Treatment-Resistant Neovascular Age-Related Macular Degeneration Patients Treated With Aflibercept

    RANZCO CLINICAL AUDIT TOOL (RCAT)

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    RANZCO CLINICAL AUDIT TOOL (RCAT)

    RANZCO CLINICAL AUDIT TOOL (RCAT)

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

RECENT MEETINGS


2019 RANZCO, 51st Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
08 November – 12 November 2019
Sydney, Australia
2018 RANZCO, 50th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
17 November - 21 November 2018
Adelaide Convention Centre, South Australia

ARCHIVES

© COPYRIGHT 2016 The Royal Australian and New Zealand College of Ophthalmologists